Related Experiment Video
Updated: Jun 22, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based
Abdel Aziz M Shaheen1, Gilaad G Kaplan, James N Hubbard
1Liver Unit, Department of Medicine, Division of Gastroenterology, University of Calgary, Calgary, AB, Canada.
Insights
Patients with cirrhosis undergoing coronary artery bypass graft (CABG) surgery face significantly higher risks of mortality and complications. This population-based study highlights the increased morbidity and mortality associated with CABG in cirrhotic patients.
Area of Science:
- Cardiovascular Surgery
- Hepatology
- Transplantation
Background:
- The surgical risks for patients with cirrhosis undergoing coronary artery bypass graft (CABG) surgery are not well-established.
- This study aimed to define the outcomes of CABG in patients with cirrhosis from a population-based perspective.
Purpose of the Study:
- To evaluate the outcomes of coronary artery bypass graft (CABG) surgery in patients diagnosed with cirrhosis.
- To assess the impact of cirrhosis on mortality, complications, length of stay, and healthcare charges following CABG.
Main Methods:
- Analysis of the 1998-2004 Nationwide In-patient Sample database to identify patients undergoing CABG.
- Logistic regression models were employed to assess the effect of cirrhosis on key outcomes.
Main Results:
- Cirrhotic patients (0.2% of total) had a significantly increased risk of mortality (17% vs. 3%) and complications (43% vs. 28%) after CABG.
- Cirrhosis was associated with longer hospital stays and higher charges (P<0.0001).
- Predictors of mortality included age, female gender, ascites, and congestive heart failure; hospital volume and off-pump CABG did not impact mortality.
Conclusions:
- Patients with cirrhosis experience a substantially elevated risk of morbidity and mortality post-CABG surgery.
- Further research is needed to improve risk stratification for this high-risk group.
Background:
The risk of cardiac surgery in patients with cirrhosis is poorly defined. Our objective was to describe outcomes of coronary artery bypass graft (CABG) surgery in cirrhotic patients from a population-based perspective.
Methods:
We analysed the 1998-2004 Nationwide In-patient Sample to identify patients hospitalized for CABG surgery. The effect of cirrhosis on mortality, complications, length of stay (LOS) and charges was evaluated using logistic regression models.
Results:
Between 1998 and 2004, there were 403 094 CABG admissions; 711 patients (0.2%) had cirrhosis. The average annual number of surgeries increased 4.2% [95% confidence interval (CI) 0.7-7.8] in cirrhotic patients, but decreased 5.5% (3.4-7.5) in non-cirrhotic patients. Patients with cirrhosis had an increased risk of mortality [17 vs. 3%; adjusted odds ratio (OR) 6.67; 95% CI 5.31-8.31], complications [43 vs. 28%; OR 1.99 (95% CI 1.72-2.30)] and greater LOS and charges (P<0.0001). Predictors of mortality included age over 60 (OR 2.21; 95% CI 1.31-3.73), female gender (OR 1.92; 95% CI 1.08-3.41), ascites (OR 3.80; 95% CI 1.95-7.39) and congestive heart failure (OR 1.75; 95% CI 1.08-2.84). Hospital volume and off-pump CABG did not affect mortality.
Conclusions:
Patients with cirrhosis have an increased risk of morbidity and mortality following CABG surgery. Additional studies are necessary to refine risk stratification in this high-risk patient population.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...